Piotr Swat / Shutterstock.com
25 October 2019AmericasSarah Morgan
AbbVie and AstraZeneca settle cancer drug patent suits
AbbVie and AstraZeneca reached a settlement over patent suits involving their rival cancer drugs earlier this week, after nearly two years of litigation.
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
Generics
19 October 2021 AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga.
Editor's picks
Editor's picks
Generics
19 October 2021 AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga.
Generics
19 October 2021 AstraZeneca has convinced a federal court to uphold challenged claims of a patent related to its diabetes drug Farxiga.